- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06443320
Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders (VIDEOTSA)
May 30, 2024 updated by: Centre Hospitalier Intercommunal Robert Ballanger
Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities.
These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities.
Communication tools like PECS or Makaton and social skills groups have shown effectiveness but have limitations, particularly not addressing sensory atypicalities seen in children with ASD.
These sensory atypicalities are evident when children watch videos on screens.
The idea is to use video to understand the sensory experiences of children with ASD and help them move away from an isolated relationship with screens.
New technologies can further isolate children with ASD in their autistic sphere.
The hypothesis is that observing these children with screens will provide better understanding of their sensory experiences and improve therapeutic support towards play and interaction with others
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mathilde ZERR
- Phone Number: 0182372332
- Email: mathilde.zerr@ght-gpne.fr
Study Contact Backup
- Name: Constance LEMARCHAND
- Phone Number: 0149367250
- Email: constance.lemarchand@ght-gpne.fr
Study Locations
-
-
-
Aulnays-sous-bois, France, 93600
- Recruiting
- CHI Robert Ballanger
-
Contact:
- Mathilde ZERR
- Phone Number: 0182372332
- Email: mathilde.zerr@ght-gpne.fr
-
Contact:
- Constance LEMARCHAND
- Phone Number: 01 49 36 72 50
- Email: constance.lemarchand@ght-gpne.fr
-
Sub-Investigator:
- Virginie CRUVEILLER
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children aged 3 to 12 years.
- Clinically confirmed ASD by a psychiatrist.
- Parental or legal guardian consent for participation.
- Child showing a strong interest in screens and/or video content.
- Ability to tolerate the presence of other children.
- Minimum of 9 video drama sessions.
- Not having benefited from disease care in the past.
- Affiliation to a social security system
Exclusion Criteria:
- No ASD diagnosis.
- Younger than 3 or older than 12 at the study start.
- No interest in screens or video content.
- Parental or legal guardian refusal for participation.
- Dropping out before completing 9 sessions.
- Patient having benefited a disease care in the past
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group of young ASD patients receiving videodrama sessions and interviews
Children participating in videodrama sessions, one per week for 9 sessions.
|
Patients will benefit from videodrama sessions, one per week for 9 sessions
|
No Intervention: Cohort of ASD patients not receiving videodrama but receiving care in participating units
Patients included in the cohort will be managed as part of their routine care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dunn Sensory Profile questionnaire
Time Frame: 9 months
|
Sensory atypicality frequency will be assessed using the Dunn Sensory Profile questionnaire, describing child behavior in various sensory experiences
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cars-T questionnaire
Time Frame: 9 months
|
Observe improvements in social skills (interaction and communication) in children with ASD, assessed by the Cars-T questionnaire,
|
9 months
|
Sceno Test
Time Frame: 9 months
|
Observation of the emergence of a symbolic game.
This emergence will be evaluated by the passation of the scenotest, a test which reveals the different modalities of integration of the game.
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2023
Primary Completion (Estimated)
March 4, 2027
Study Completion (Estimated)
March 4, 2027
Study Registration Dates
First Submitted
May 30, 2024
First Submitted That Met QC Criteria
May 30, 2024
First Posted (Actual)
June 5, 2024
Study Record Updates
Last Update Posted (Actual)
June 5, 2024
Last Update Submitted That Met QC Criteria
May 30, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GHT_CHIRB 20220420
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder (ASD)
-
Hoffmann-La RocheCompletedAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
University of LincolnNottinghamshire Healthcare NHS TrustRecruiting
-
SciSparcNegev Autism Center Soroka University Medical CenterNot yet recruiting
-
EarliTec Diagnostics, IncCompletedAutism Spectrum Disorder (ASD)United States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, Hungary, Poland, Brazil, France, Italy, Portugal, United Kingdom, Germany, Netherlands
Clinical Trials on videodrama sessions
-
University of Southern CaliforniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedEarly Child DevelopmentUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Michigan State UniversityNational Cancer Institute (NCI)Completed
-
International Centre for Diarrhoeal Disease Research...Population Council; Marie Stopes International; Bangladesh Legal Aid and Services... and other collaboratorsCompletedSexual and Reproductive Health and Rights | Violence Against Women and Girls
-
The University of Hong KongThe Hong Kong Jockey Club Charities Trust; Hong Kong Island Women AssociationUnknownPhysical Activity | Well-being | Healthy Diet | FamilyHong Kong
-
London Health Sciences CentreChildren's Hospital Medical Center, CincinnatiNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | IBD
-
NYU Langone HealthWithdrawnFamilial DysautonomiaUnited States
-
Cairo UniversityUnknown
-
University Hospital, ToulouseCentre National de la Recherche Scientifique, FranceRecruitingAttention Deficit | Hyperactivity DisorderFrance
-
University of KansasEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPhysical Activity | Intellectual Disability | Down Syndrome | Adolescent BehaviorUnited States